Diagnostic modalities of non-alcoholic fatty liver disease: from biochemical biomarkers to multi-omics non-invasive approaches
E Martinou, M Pericleous, I Stefanova, V Kaur… - Diagnostics, 2022 - mdpi.com
Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the most common cause of chronic
liver disease worldwide, and its prevalence is increasing globally. NAFLD is a multifaceted …
liver disease worldwide, and its prevalence is increasing globally. NAFLD is a multifaceted …
Nonalcoholic fatty liver disease (NAFLD): pathogenesis and noninvasive diagnosis
The global prevalence of nonalcoholic fatty liver disease (NAFLD) or metabolic associated
fatty liver disease (MAFLD), as it is now known, has gradually increased. NAFLD is a …
fatty liver disease (MAFLD), as it is now known, has gradually increased. NAFLD is a …
[HTML][HTML] Nonalcoholic fatty liver disease: an update on the diagnosis
Nonalcoholic fatty liver disease (NAFLD) is a common liver disease and a major cause of
related complications such as cirrhosis and hepatocellular carcinoma (HCC). NAFLD …
related complications such as cirrhosis and hepatocellular carcinoma (HCC). NAFLD …
Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
Noninvasive biomarkers in NAFLD and NASH—current progress and future promise
VWS Wong, LA Adams, V de Lédinghen… - Nature reviews …, 2018 - nature.com
Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is
the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is …
the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is …
Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is considered to be the hepatic manifestation of
the metabolic syndrome and is characterized by ectopic accumulation of triglycerides in the …
the metabolic syndrome and is characterized by ectopic accumulation of triglycerides in the …
Advance of serum biomarkers and combined diagnostic panels in nonalcoholic fatty liver disease
Y Zeng, H He, Z An - Disease Markers, 2022 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) affects approximately 25‐30% population
worldwide, which progresses from simple steatosis to nonalcoholic steatohepatitis (NASH) …
worldwide, which progresses from simple steatosis to nonalcoholic steatohepatitis (NASH) …
Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?
N Alkhouri, AE Feldstein - Metabolism, 2016 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of
chronic liver disease in the United States affecting approximately 80–100 million Americans …
chronic liver disease in the United States affecting approximately 80–100 million Americans …
[HTML][HTML] Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease
KC Hu, HY Wang, SC Liu, CC Liu… - World journal of …, 2014 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) refers to the accumulation of fat (mainly
triglycerides) within hepatocytes. Approximately 20%-30% of adults in the general …
triglycerides) within hepatocytes. Approximately 20%-30% of adults in the general …
[HTML][HTML] Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
With the increasing number of individuals with diabetes and obesity, nonalcoholic fatty liver
disease (NAFLD) is becoming increasingly prevalent, affecting one-quarter of adults …
disease (NAFLD) is becoming increasingly prevalent, affecting one-quarter of adults …